CME Group’s Chief Executive, Terrence Duffy, has announced plans to initiate legal action against the U.S. Commodity Futures Trading Commission (CFTC) following the CFTC’s recent approval of perpetual futures products. Duffy expressed his concerns on CNBC, asserting that the approval does not align with the stipulations set forth by the Dodd-Frank Act, which regulates swaps and futures.
Duffy emphasized that, according to the Dodd-Frank Act, the definitions of swaps and futures are well-established. He highlighted that when two parties exchange payments, this arrangement should classify as a swap, not a future. “These products that he supposedly approved as futures are not futures; they would be swaps,” Duffy stated. If deemed swaps, this designation would necessitate adherence to stricter regulations specific to the swap market, which differ from those applied to futures.
As Duffy prepares to step down from his position next year, he reiterated the importance of understanding regulatory guidelines before CME considers introducing its own perpetual futures contracts. He noted that the current rules surrounding these products are ambiguous, making it difficult for the organization to navigate potential listings. This legal challenge marks a significant development in the ongoing discourse about market regulation and product classification in the derivatives landscape.
